GlassScriptPhysician profile
Zachary Virgin
NPI 1851731103
$4,054.89
in general payments reported to CMS, 2019-2025
19 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,130 · 2020: $718 · 2021: $209 · 2022: $119 · 2023: $179 · 2024: $346 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,336.17 | 2019-2025 | Gore Excluder Iliac Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Medtronic, INC. | $446.73 | 2021-2025 | In.Pact Admiral, V-Loc 180, Venaseal |
| Boston Scientific Corporation | $229.87 | 2019-2025 | Eluvia, General - Balloons, General - Thrombectomy |
| Bard Peripheral Vascular, INC. | $148.51 | 2020-2021 | |
| Endologix LLC | $137.45 | 2020 | |
| Inari Medical, INC. | $132.62 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cook Medical LLC | $126.91 | 2019-2025 | Zilver Ptx |
| Silk Road Medical, INC. | $117.42 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic Vascular, INC. | $96.25 | 2020 | |
| Lemaitre Vascular, INC. | $71.96 | 2024 | Hydro Lemaitre Valvulotome |
| Baxter Healthcare | $34.69 | 2023 | Preveleak |
| Mozarc Medical US LLC | $33.30 | 2024 | Palindrome |
| Penumbra, INC. | $29.82 | 2025 | Pod |
| Abbott Laboratories | $23.49 | 2024 | Esprit |
| Kerecis Limited | $22.92 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $19.74 | 2024 | Sir-Spheres Microspheres |
| Chiesi USA, INC. | $17.85 | 2019 | |
| Cashflow Solutions, LLC | $14.69 | 2025 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Solventum Corporation | $14.50 | 2024 | V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Virgin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.